Hematology and Blood Banking for Medical Students

Mastering the fundamentals of hematology and transfusion medicine is non-negotiable for your clinical success. This knowledge is critical not only for passing your USMLE exams but also for making rapid, accurate decisions in any hospital setting, from the emergency room to the intensive care unit. Your ability to interpret a complete blood count, diagnose a bleeding disorder, or safely order a blood transfusion directly impacts patient outcomes.

Red Blood Cell Disorders and Anemias

The primary function of red blood cells (RBCs) is oxygen delivery via hemoglobin, a tetrameric protein containing iron. Disorders arise from problems in production, survival, or loss. Anemias are classified by RBC size, measured as mean corpuscular volume (MCV), which guides your diagnostic pathway.

Microcytic anemias (low MCV) are often due to impaired hemoglobin synthesis. Iron deficiency anemia is the most common global cause, characterized by low serum ferritin, increased total iron-binding capacity (TIBC), and low serum iron. In contrast, anemia of chronic disease involves functional iron deficiency due to inflammation trapping iron in macrophages, showing low serum iron and low TIBC. Thalassemias are quantitative hemoglobinopathies caused by reduced synthesis of alpha or beta globin chains, leading to microcytosis with a disproportionately high RBC count and target cells on smear. Hemoglobin electrophoresis helps confirm beta-thalassemia.

Normocytic anemias can result from acute blood loss, bone marrow failure (aplastic anemia), or premature destruction. Hemolytic anemias feature increased reticulocytes, elevated indirect bilirubin, and low haptoglobin. Causes are intrinsic (e.g., sickle cell disease, G6PD deficiency, spherocytosis) or extrinsic (e.g., autoimmune, microangiopathic as seen in thrombotic thrombocytopenic purpura [TTP]).

Macrocytic anemias are subdivided. Megaloblastic macrocytosis is caused by impaired DNA synthesis, most commonly from vitamin B12 deficiency (leading to neurological symptoms like subacute combined degeneration) or folate deficiency. Non-megaloblastic causes include liver disease, hypothyroidism, and certain drugs.

White Blood Cell Disorders and Coagulation Fundamentals

White blood cell (WBC) disorders involve quantitative or qualitative defects. Leukocytosis (high WBC count) is often reactive (e.g., infection, stress), while persistent elevations raise concern for myeloproliferative neoplasms or leukemia. Leukopenia (low WBC count), particularly neutropenia, increases infection risk and can be due to drugs, autoimmune conditions, or bone marrow infiltration.

The coagulation cascade is a series of amplifying enzymatic reactions culminating in fibrin clot formation. It's traditionally divided into the intrinsic, extrinsic, and common pathways, but a cell-based model is more physiologically accurate. Key vitamin K-dependent factors (II, VII, IX, X) are synthesized in the liver. The prothrombin time (PT) tests the extrinsic and common pathways (Factors VII, X, V, II, fibrinogen), while the activated partial thromboplastin time (aPTT) tests the intrinsic and common pathways (Factors XII, XI, IX, VIII, X, V, II, fibrinogen).

Bleeding Disorders and Thrombotic Conditions

Bleeding disorders are categorized by which screening test is abnormal. A prolonged PT only suggests Factor VII deficiency (e.g., early warfarin effect). A prolonged aPTT only suggests issues with the intrinsic pathway (e.g., hemophilia A [Factor VIII deficiency] or hemophilia B [Factor IX deficiency]). Hemophilias are X-linked recessive, causing spontaneous joint and soft tissue bleeding. A mixing study corrects if a factor deficiency is present but not if an inhibitor (like an antibody) is present. Both PT and aPTT prolonged? Think of disseminated intravascular coagulation (DIC), liver disease, or a common pathway defect like Factor X deficiency.

Von Willebrand disease is the most common inherited bleeding disorder. Von Willebrand factor (vWF) has two key roles: it carries Factor VIII in plasma and mediates platelet adhesion to damaged subendothelium. Deficiency causes a prolonged bleeding time and aPTT (due to low Factor VIII), with mucocutaneous bleeding (epistaxis, menorrhagia).

Thrombotic conditions involve inappropriate clot formation. Deep vein thrombosis (DVT) and pulmonary embolism (PE) are classic presentations of venous thromboembolism (VTE). Risk factors are summarized by Virchow's Triad: stasis, hypercoagulability, and endothelial injury. Hypercoagulable states can be inherited (e.g., Factor V Leiden mutation, which causes activated protein C resistance; prothrombin gene mutation) or acquired (e.g., malignancy, antiphospholipid syndrome).

Blood Typing, Crossmatching, and Transfusion

Safe transfusion begins with blood typing and crossmatching. The ABO system is the most critical. Individuals have pre-formed IgM antibodies against the ABO antigens they lack: Type A has anti-B, Type B has anti-A, Type O has both, and Type AB has neither. The Rh system is next most important; anti-D antibodies are IgG and can cross the placenta, causing hemolytic disease of the fetus and newborn.

Crossmatching is the final check for compatibility. A "type and screen" identifies the patient's blood type and screens their serum for unexpected antibodies. A "type and cross" goes further, mixing recipient serum with donor RBCs to confirm compatibility before issuing units.

Component therapy allows targeted treatment. Packed red blood cells (pRBCs) increase oxygen-carrying capacity. Platelets are used for thrombocytopenia or platelet dysfunction. Fresh frozen plasma (FFP) contains all coagulation factors. Cryoprecipitate is rich in fibrinogen, Factor VIII, and vWF.

Transfusion Reactions and Complications

Recognizing transfusion reactions is a vital clinical skill. Acute hemolytic reactions are often due to ABO incompatibility, causing fever, pain, hypotension, and dark urine (hemoglobinuria) from intravascular hemolysis; treatment is to STOP the transfusion immediately, provide supportive care, and investigate the error.

Febrile non-hemolytic reactions (from donor WBC cytokines) and allergic reactions (mild urticaria to anaphylaxis) are common. Transfusion-related acute lung injury (TRALI) presents as acute hypoxemia and non-cardiogenic pulmonary edema during or soon after transfusion, mediated by donor antibodies. Transfusion-associated circulatory overload (TACO) presents with pulmonary edema due to volume overload. Slowing the transfusion and using diuretics is key. Immunosuppressed patients are at risk for transfusion-associated graft-versus-host disease, prevented by irradiating cellular blood products.

Common Pitfalls

1. Confusing Hemophilia and von Willebrand Disease: Hemophilia (A/B) causes prolonged aPTT, spontaneous joint bleeding, and is X-linked. Von Willebrand disease causes prolonged bleeding time (and often aPTT), mucocutaneous bleeding, and is usually autosomal dominant. Giving DDAVP can raise vWF and Factor VIII in mild von Willebrand disease, but it's ineffective in hemophilia A with severe deficiency.
2. Misinterpreting Anemia Labs: Starting a workup without an MCV is a common error. Ordering a B12/folate level for every anemia wastes resources; reserve it for macrocytic or specific clinical contexts. In microcytic anemia, remember that a low serum ferritin is diagnostic for iron deficiency, while a normal or high ferritin in an inflammatory state does not rule out concurrent iron deficiency.
3. Mismanaging Anticoagulation Reversal: Reversing warfarin with FFP is slow; for major bleeding, use 4-factor prothrombin complex concentrate (PCC) for rapid reversal. Reversing heparin with protamine is appropriate. For direct oral anticoagulants (DOACs), identify the specific agent and time since last dose; specific reversal agents exist for some (e.g., idarucizumab for dabigatran).
4. Overlooking TTP: In a patient with microangiopathic hemolytic anemia (schistocytes on smear), thrombocytopenia, and neurological symptoms, do not wait for confirmatory labs (low ADAMTS13 activity) to suspect TTP. It is a hematologic emergency requiring immediate plasma exchange.

Summary

• Diagnose anemia systematically using the MCV (microcytic, normocytic, macrocytic) and reticulocyte count to guide your investigation into production, destruction, or loss.
• Master coagulation tests: PT (extrinsic pathway) and aPTT (intrinsic pathway) are your primary screens for bleeding disorders. Use mixing studies to differentiate factor deficiencies from inhibitors.
• Know the high-yield disorders: Iron deficiency, anemia of chronic disease, thalassemia, hemolytic anemias, hemophilia, von Willebrand disease, and common thrombophilias like Factor V Leiden.
• Prioritize transfusion safety: ABO compatibility is absolute. Recognize and act swiftly on transfusion reactions—stop the transfusion for any suspected acute hemolytic reaction.
• Apply component therapy wisely: Use pRBCs for anemia, platelets for significant thrombocytopenia/bleeding, FFP for multiple factor deficiencies, and cryoprecipitate for hypofibrinogenemia.
• Remember the emergencies: Conditions like TTP (pentad of symptoms), acute hemolytic transfusion reaction, and major bleeding on anticoagulants require immediate, specific interventions.